Lina M Rosa, clinical psychopathologist

Psychologist graduated from Corporacion Universitaria del Caribe (CECAR) Sincelejo, Colombia and the University of Zaragoza (Spain). She holds a master’s degree in clinical psychopathology (UAB – Barcelona) and a postgraduate degree in clinical neuropsychology (ISEP – Barcelona). She is the founder and director of FARFALLA, a diagnostic and intervention unit specializing in clinical neuropsychology and neurodevelopmental disorders. Since 2016, she has been part of the “Colombia Project of Hope”. She is an advisor to the Fragile X Association Colombia, Fundautismo and the Dunya Autism Project that is carried out in Morocco. Dr. Rosa is also a professor at the School of Social Sciences and Humanities at CECAR Sincelejo, Colombia.

Lorena Ivette Santa María Vasquez, PhD

Dr Santa Maria is the director of the Molecular Cytogenetic Laboratory-INTA of the Universidad de Chile that conducts clinical research in the area of ​​neurogenetics and performs updated methodologies for the molecular diagnosis of the most prevalent genetic diseases such as FXS, Prader Willi/Angelman syndrome, velocardiofacial syndrome, Williams syndrome, among others. She conducted her undergraduate and doctoral theses studying the differentiation of mesenchymal cells. She completed her postdoctoral internship at the Laboratory of Molecular and Cellular Neurobiology of the Faculty of Medicine of the Universidad de Chile. In 2008, she returned to work at the Molecular Cytogenetic Laboratory in charge of MSc. M. Angélica Alliende that has been participating in the development of clinical cytogenetic research for more than 30 years, contributing to the training of new professionals and the understanding of the genetic basis of neurological and cognitive disorders of genetic diseases with intellectual deficit and/or autism. She is currently the director of the Specialization Course in Clinical Cytogenetics (Decree # 007585 Universidad de Chile) that includes a permanent update in the molecular cytogenetic diagnosis of genetic and neoplastic diseases.

Manuel F Casanova, MD

Dr. Casanova belonged to the founding board of the National Alliance for Autism Research (now Autism Speaks) and the Autism Tissue Board. He has served on the Board of Directors or Scientific Advisory Board of numerous organizations (e.g., Autism Research Institute, Generation Rescue, On Mental Health, Families for Effective Autism Treatment, Clearly Present Foundation) and is presently on the editorial board of 15 different medical journals. Among many honors Dr. Casanova was the chairperson of the Developmental Brain Disorders Study Section, received a Physicians Recognition Award by the American Medical Association, and holds a Stanley Scholars title, distinguished faculty, honorary professor and lecturer for several academic institutions. In 2016, Dr. Casanova was elected president of the International Consortium of Autism Institutes (ICAI).Dr. Casanova is a neurologist. He is the SmartState Endowed Chair in Childhood Neurotherapeutics and a professor of Biomedical Sciences at the University of South Carolina School of Medicine Greenville. He belonged to the founding board of the National Alliance for Autism Research (now Autism Speaks) and the Autism Tissue Board. He has served on the Board of Directors or Scientific Advisory Board of numerous organizations (e.g., Autism Research Institute, Generation Rescue, On Mental Health, Families for Effective Autism Treatment, Clearly Present Foundation) and is presently on the editorial board of 15 different medical journals. Among many honors Dr. Casanova was the chairperson of the Developmental Brain Disorders Study Section, received a Physicians Recognition Award by the American Medical Association, and holds a Stanley Scholars title, distinguished faculty, honorary professor and lecturer for several academic institutions. In 2016, Dr. Casanova was elected president of the International Consortium of Autism Institutes (ICAI).Dr. Casanova belonged to the founding board of the National Alliance for Autism Research (now Autism Speaks) and the Autism Tissue Board. He has served on the Board of Directors or Scientific Advisory Board of numerous organizations (e.g., Autism Research Institute, Generation Rescue, On Mental Health, Families for Effective Autism Treatment, Clearly Present Foundation) and is presently on the editorial board of 15 different medical journals. Among many honors Dr. Casanova was the chairperson of the Developmental Brain Disorders Study Section, received a Physicians Recognition Award by the American Medical Association, and holds a Stanley Scholars title, distinguished faculty, honorary professor and lecturer for several academic institutions. In 2016, Dr. Casanova was elected president of the International Consortium of Autism Institutes (ICAI).

Dr. Casanova has provided a large number of plenary lectures including a magisterial presentation at the World Congress of Autism. His research has been recognized by a EUREKA award from the NIMH for the introduction of repetitive Transcranial Magnetic Stimulation (rTMS) in the Therapy of autism spectrum disorders. He has published over 280 articles in peer reviewed journals, 125 book chapters, and edited 9 books. Dr. Casanova is the author of two recently published books “Defining Autism” (2018) and “Autism Updated” (2019).

Maria Jimena Salcedo-Arellano, MD, MBA

Dr. Salcedo is a physician. She graduated from the Universidad del Valle, Cali, Colombia. Upon graduation she joined the University of California Davis MIND Institute and currently works in the Clinical Trials Unit. She is a collaborator of the “Colombia Project of Hope” established in 2013; a humanitarian and research initiative led by Dr. Randi Hagerman, with the aim of detecting mutations associated with fragile X in populations throughout Colombia and to provide training opportunities for physicians, therapists and health care providers about FXS, autism and neurodevelopmental disorders.

She is also a research scientist at Dr. Martínez-Cerdeño’s laboratory at the University of California Davis, Department of Pathology and Laboratory Medicine, where they develop research projects in the area of neuroscience with an emphasis on neurodegenerative diseases such as fragile X-associated tremor and ataxia syndrome (FXTAS) and Parkinson’s disease and neurodevelopmental disorders like fragile X syndrome and autism spectrum disorders. She also serves as director of international events for the Ventricular Foundation.

Randi J Hagerman, MD

Doctor Hagerman is a distinguished professor of pediatrics at the University of California Davis Medical Center and director of the fragile X research and treatment center at the MIND Institute and holds an Endowed Chair in fragile X research. Dr. Hagerman is a developmental and behavioral pediatrician and has studied patients with FXS, ASD, and other neurodevelopmental disorders. She has carried out numerous targeted treatment studies in FXS and autism. She and her husband, Doctor Paul Hagerman, and her research team have published extensively regarding fragile X premutation disorders including the first description of FXTAS in 2001. She co-founded the National Fragile X Foundation in 1984 and has been involved in targeted treatments for fragile X syndrome, autism, and FXTAS for several years. Dr Hagerman has written over 400 peer-reviewed articles and several books on fragile X and autism. Her most recent books are R. Hagerman and R. Hendren (eds) (2014). Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms published by Oxford University Press and, E. Hollander, R. Hagerman and D. Fein (eds) (2018) Autism Spectrum Disorders, American Psychiatric Association Publishing.

Reymundo Lozano, MS, MD

Dr. Reymundo Lozano is an assistant professor of Psychiatry, Genetics and Genomic Sciences, and Pediatrics. He is a clinical geneticist with neurodevelopmental and aging research training. He has dedicated his research to better understanding the molecular basis of neurodevelopmental disorders including autism and dementia.

.He is the director of the FXS Clinic at Mount Sinai, New York and specializes in the treatment of FXS and FOXP1. As a collaborator on several clinical trials in FXS and autism, Dr. Lozano is committed to finding targeted treatments. Dr. Lozano’s health care leadership goals are to create new models for delivering high quality, efficient, and cost-effective care in an increasingly changing environment lead by technological advances in genetics and communication. Dr. Lozano has consulted for genetic laboratories, pharmaceutical companies and other non-profit organizations.

Robert Miller

Robert Miller is the director of clinics and international relations for the National Fragile X Foundation (NFXF). He is also the co-founder of the Fragile X Clinical & Research Consortium (FXCRC) comprised of clinical researchers and intervention professionals at clinics located in medical institutions throughout the U.S. and Canada; and the Collaboration to Promote Self-Determination – now a highly regarded Washington, DC advocacy organization. He served as the executive director for the NFXF for more than 14 years. His work has helped increase overall awareness of fragile X-associated disorders which led to many more thousands of families receiving help.

Stephen C Noctor, PhD

Dr. Noctor is an associate professor of Psychiatry at the University of California, Davis. He earned his doctorate from Uniformed Services University Health Sciences (USUHS) in Washington and his postdoctoral training at Columbia University in New York and University of California San Francisco. Dr. Noctor’s lab investigates the factors that regulate the function of the stem cells that produce neurons and glial cells that make up the cerebral cortex. The most recent work of this laboratory focuses on the relationships of the immune system with the nervous system during prenatal development of the cerebral cortex.

Verónica Martínez-Cerdeño, PhD

Verónica Martínez-Cerdeño, is an associate professor at the Department of Pathology and Laboratory Medicine at UC Davis School of Medicine and faculty at the Institute of Pediatric Regenerative Medicine, Shriners Hospital for Children of Northern California, and the MIND Institute. She is a CAMPOS Scholar who was selected for her leadership potential to impact their STEM discipline in profound and enduring ways. She has published more than 70 peer-reviewed articles and participated in seven books. She has been and is Primary Investigator (PI) for multiple NIH (R01s) and other grants and is a member of the NIH Neurogenesis and Cell Fate Study Section. She is external adviser for the University of Puerto Rico School of Medicine.

Dr. Martínez-Cerdeño is the director of the UC Davis FXS/FXTAS brain repository, and the founder and director for CENE -Banco hispano-americano de cerebros de enfermedades del neurodesarrollo – The Hispanic-American Brain Bank for Neurodevelopmental Diseases- the first brain bank for neurodevelopmental conditions in Latin America, with nodes in California, México, Colombia, and Puerto Rico. She is also the founder and CEO of The Ventricular Foundation, a non-profit organization that teaches about the benefit of outreach activities and science, to students of all ages, the scientific community, and the public in general, with an emphasis on underrepresented students. She is the co-founder and scientific director of LUNAS (Latinos Unidos Navegando el Autismo y Servicios) project, a multimedia community approach to empower multilanguage parents to educate, navigate, and be successful at obtaining all the services available to their children affected by ASD in California.

Wilmar Saldarriaga, MD, PhD

Doctor Saldarriaga is a professor of genetics, embryology and congenital malformations at the Universidad del Valle School of Medicine. He is the director of the research group in Congenital Malformations, Dysmorphology and Medical Genetics MACOS of the Universidad del Valle with category A in COLCIENCIAS. In addition, it has 80 publications in national and international indexed journals. He is the author and editor of the books “Foundations of Obstetrics and Gynecology”, “Integrated Human Embryology” and “Fragile X Syndrome in Ricaurte, Colombia”.

Professor Saldarriaga was director of the Medical School at the Universidad del Valle, Cali Colombia. In 2014 he received the ASCOFAME award for “Best Medical Educator in Colombia” in the category of young educators. In October 2017 he received a meritorious mention for his doctoral thesis in biomedical sciences with an emphasis on medical genetics at the Universidad del Valle. In addition, during his senior year of doctoral studies, he completed a 1-year training program at the University of California Davis MIND Institute. He is currently the Vice-Chair of research of the Faculty of Health at the Universidad del Valle.